After regulatory review, U.S. Food and Drug Administration (FDA) approved genetically engineered (GE) AquAdvantage® Salmon for commercial marketing. In response, BIO President and CEO Jim Greenwood commended the FDA "for taking this very important step in the right direction for the advancement of animal biotechnology innovation." AquAdvantage Salmon, developed by BIO member AquaBounty Technologies, is genetically engineered to reach market weight earlier while using 25% less food.